Word: question
(lookup in dictionary)
(lookup stats)
Dates: all
Sort By: most recent first
(reverse)
...your savings away,’ or playing with money you can’t afford to lose. My cousin asked me the other day, ‘So, can you sit down at the table and lose your house?’ It’s a legitimate question, but it’s taken a while to explain to my parents that if you do it properly, it’s a lot like managing your portfolios. Could you lose everything you own in the stock market? Sure you could. But you can balance your portfolio such that...
This week, Will tries to write a mash-up for Emma and Ken’s wedding while struggling with his desire to steal her away. The popular crossover members of glee suffer in McKinley High’s social hierarchy, and the football boys question their commitment to New Directions. Puck and Rachel make out, Sue Sylvester falls in love (!?), and Ken almost kills glee...
...Generic Nudge The question before Waxman's committee last summer was this: How many years of monopoly protection should be afforded to biotechnology drugs, known as biologics, before cheaper alternatives are allowed on the market? These miraculous drugs - which differ from traditional, chemical-based pharmaceuticals because they are derived from living matter - are widely regarded as the future of the pharmaceutical industry and, indeed, of medicine itself. While only 20% of drugs on the market today are biologics, it is expected that, with 633 biotechnology medicines in development last year for more than 100 diseases, half the new drugs approved...
...Congress, committee chairmen are known as the old bulls for a reason: it's unwise to provoke them. So it isn't often that you see one get rolled by his own committee - especially when the chairman in question is the formidable and canny Henry Waxman and the issue in question is one that matters a lot to him. But that was what happened on July 31 as the House Energy and Commerce Committee was putting the final touches on health-reform legislation. Waxman's fellow California Democrat Anna Eshoo offered a last-minute amendment that Waxman opposed. Knowing...
...dilemma: policymakers want to foster cost-saving competition without killing the financial incentives that have put the U.S. biotechnology industry at the vanguard of medical science and without stifling the development of even more drugs that could save lives and eliminate suffering. Finding that equilibrium goes to the question of how long biotech firms should be guaranteed exclusivity, outside the protection of their patents, before copycats can begin using the data they have developed...